The project will be the largest investment in the university's history, costing an estimated $75 million for the medical facility alone.
The FDA's green light for GOMEKLI is a significant achievement for SpringWorks, especially as it comes with a rare pediatric disease priority review voucher, which could be valued at around $100 ...
Oppenheimer analyst Param Singh initiated coverage of IBM stock with an Outperform rating and a $320 price target.
Megakaryocytes form a three-dimensional (3D) cage composed of laminin and collagen IV connected to the basement membrane surrounding them. This microarchitecture stabilizes megakaryocytes within their ...